EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irritable bowel syndrome: Clinical approach and therapeutic strategies

Zoran Joksimović, Dušan Bastać, Snežana Pavlović

Timocki medicinski glasnik · 2026 · 51 (1) · 49-57

DOI: 10.5937/tmg2601049j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Timocki medicinski glasnik, 2026. Verfasst von Zoran Joksimović und 2 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by recurrent abdominal pain associated with changes in stool frequency and consistency. Symptoms vary in both intensity and frequency. IBS is classified into subtypes: IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), mixed IBS (IBS-M), and unclassified IBS (IBS-U). The etiopathogenesis is multifactorial and includes visceral hypersensitivity, alterations in central nervous system pain processing, motility disturbances, immune activation, gut microbiota dysbiosis, and increased intestinal permeability. Psychological factors, stress, and childhood trauma further modulate symptom expression. The prevalence of IBS is estimated at 10-15% of the general population, with higher incidence in women and individuals under 50 years of age. Genetic and familial factors contribute to susceptibility, while acute gastroenteritis and post-infectious states represent important triggers. Epidemiological data suggest relatively stable prevalence over time, with spontaneous remission occurring in a subset of patients. The diagnostic approach is based on the Rome IV criteria and a positive diagnostic strategy, with exclusion of alarm symptoms and selective laboratory evaluation. Treatment is individualized according to subtype, dominant symptoms, and psychosocial burden. Core interventions include patient education, dietary modification, and pharmacotherapy, while neuromodulators, probiotics, and psychological interventions play an important role in patients with marked visceral hypersensitivity or refractory symptoms. Understanding IBS through a biopsychosocial model enables a rational and personalized approach to diagnosis and therapy, aiming to reduce symptoms, improve functional status, and enhance quality of life. Psychological therapies and complementary approaches, including cognitive-behavioral therapy, hypnotherapy, and stress-reduction techniques, contribute to long-term improvement in patients' quality of life.

Zitieren

APA

Joksimović, Z., Bastać, D., & Pavlović, S. (2026). Irritable bowel syndrome: Clinical approach and therapeutic strategies. Timocki medicinski glasnik, 51(1), 49-57. https://doi.org/10.5937/tmg2601049j

Vancouver

Joksimović Z, Bastać D, Pavlović S. Irritable bowel syndrome: Clinical approach and therapeutic strategies. Timocki medicinski glasnik. 2026;51(1):49-57. doi:10.5937/tmg2601049j

BibTeX
@article{Joksimovi2026,
  author = {Joksimović, Zoran and Bastać, Dušan and Pavlović, Snežana},
  title = {Irritable bowel syndrome: Clinical approach and therapeutic strategies},
  journal = {Timocki medicinski glasnik},
  year = {2026},
  volume = {51},
  number = {1},
  pages = {49--57},
  doi = {10.5937/tmg2601049j}
}
Kostenlos starten →